PAPD5-mediated 3'adenylation and subsequent degradation of miR-21 is disrupted in proliferative disease.

J. Boele, H. Persson, J.W. Shin, Y. Ishizu, I.S. Newie, R. Sokilde, S.M. Hawkins, C. Coarfa, K. Ikeda, K.-I. Takayama, K. Hori-Inoue, Y. Ando, A. Maxwell Burroughs, C. Sasaki, C. Suzuki, M. Sakai, S. Aoki, A. Ogawa, A. Hasegawa, M. LizioK. Kaida, B. Teusink, P. Caminic, H. Suzuki, S. Inoue, P.H. Gunaratne, C. Rovira, Y. Hayashizaki, M.J.L. de Hoon

Research output: Contribution to JournalArticleAcademicpeer-review


Next-generation sequencing experiments have shown that micro-RNAs (miRNAs) are expressed in many different isoforms (isomiRs), whose biological relevance is often unclear. We found that mature miR-21, the most widely researched miRNA because of its importance in human disease, is produced in two prevalent isomiR forms that differ by 1 nt at their 3′ end, and moreover that the 3? end of miR-21 is posttranscriptionally adenylated by the noncanonical poly(A) polymerase PAPD5. PAPD5 knockdown caused an increase in the miR-21 expression level, suggesting that PAPD5-mediated adenylation of miR-21 leads to its degradation. Exoribonuclease knockdown experiments followed by small-RNA sequencing suggested that PARN degrades miR-21 in the 3′-to-5′ direction. In accordance with this model, microarray expression profiling demonstrated that PAPD5 knockdown results in a down-regulation of miR-21 target mRNAs. We found that disruption of the miR-21 adenylation and degradation pathway is a general feature in tumors across a wide range of tissues, as evidenced by data from The Cancer Genome Atlas, as well as in the noncancerous proliferative disease psoriasis. We conclude that PAPD5 and PARN mediate degradation of oncogenic miRNA miR-21 through a tailing and trimming process, and that this pathway is disrupted in cancer and other proliferative diseases.
Original languageEnglish
Pages (from-to)11467-11472
JournalProceedings of the National Academy of Sciences of the United States of America
Issue number31
Publication statusAccepted/In press - 2014


Dive into the research topics of 'PAPD5-mediated 3'adenylation and subsequent degradation of miR-21 is disrupted in proliferative disease.'. Together they form a unique fingerprint.

Cite this